Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its management team's upcoming participation in two major investor conferences in February 2025. The company will engage in fireside chats at:
• The Guggenheim SMID Cap Biotech Conference on Thursday, February 6th, at 6:00 a.m. PT / 9:00 a.m. ET
• The Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12th, at 7:00 a.m. PT / 10:00 a.m. ET
Interested parties can access a live webcast through the events section of the Tarsus website. Replay recordings will be made available within 48 hours of each event and will remain accessible for a time.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha annunciato la partecipazione del suo team di gestione a due importanti conferenze per investitori a febbraio 2025. L'azienda parteciperà a discussioni informali presso:
• La Guggenheim SMID Cap Biotech Conference giovedì 6 febbraio, alle 6:00 PT / 9:00 ET
• La Oppenheimer 35th Annual Healthcare Life Sciences Conference mercoledì 12 febbraio, alle 7:00 PT / 10:00 ET
Le parti interessate possono accedere a una trasmissione web in diretta attraverso la sezione eventi del sito web di Tarsus. Le registrazioni delle ripetizioni saranno disponibili entro 48 ore da ciascun evento e resteranno accessibili per un certo periodo di tempo.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha anunciado la próxima participación de su equipo directivo en dos importantes conferencias de inversionistas en febrero de 2025. La compañía participará en charlas informales en:
• La Guggenheim SMID Cap Biotech Conference el jueves 6 de febrero, a las 6:00 a.m. PT / 9:00 a.m. ET
• La Oppenheimer 35th Annual Healthcare Life Sciences Conference el miércoles 12 de febrero, a las 7:00 a.m. PT / 10:00 a.m. ET
Las partes interesadas pueden acceder a una transmisión en vivo a través de la sección de eventos del sitio web de Tarsus. Las grabaciones de repetición estarán disponibles dentro de las 48 horas posteriores a cada evento y permanecerán accesibles por un tiempo.
타르수스 제약 (NASDAQ: TARS)은 2025년 2월에 열리는 두 개의 주요 투자자 회의에 경영진이 참석할 예정이라고 발표했습니다. 회사는 다음과 같은 포럼에 참여할 것입니다:
• 구겐하임 SMID 캡 생명공학 회의는 2월 6일 목요일 오전 6:00 PT / 오전 9:00 ET에 개최됩니다.
• 오펜하이머 제35회 연례 헬스케어 생명과학 회의는 2월 12일 수요일 오전 7:00 PT / 오전 10:00 ET에 진행됩니다.
관심 있는 분들은 타르수스 웹사이트의 이벤트 섹션을 통해 생중계를 통해 액세스할 수 있습니다. 각 이벤트 후 48시간 이내에 재방송 녹화가 제공되며, 일정 기간 동안 액세스할 수 있게 됩니다.
Tarsus Pharmaceuticals (NASDAQ: TARS) a annoncé que l'équipe de direction participera prochainement à deux grandes conférences pour investisseurs en février 2025. L'entreprise participera à des discussions informelles lors des événements suivants :
• La Guggenheim SMID Cap Biotech Conference le jeudi 6 février, à 6h00 PT / 9h00 ET
• La Oppenheimer 35th Annual Healthcare Life Sciences Conference le mercredi 12 février, à 7h00 PT / 10h00 ET
Les parties intéressées peuvent accéder à un webinaire en direct via la section événements du site internet de Tarsus. Les enregistrements des rediffusions seront disponibles dans les 48 heures suivant chaque événement et resteront accessibles pendant un certain temps.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat die bevorstehende Teilnahme seines Management-Teams an zwei wichtigen Investorenkonferenzen im Februar 2025 angekündigt. Das Unternehmen wird an informellen Gesprächen teilnehmen bei:
• Der Guggenheim SMID Cap Biotech Conference am Donnerstag, den 6. Februar, um 6:00 Uhr PT / 9:00 Uhr ET
• Der Oppenheimer 35th Annual Healthcare Life Sciences Conference am Mittwoch, den 12. Februar, um 7:00 Uhr PT / 10:00 Uhr ET
Interessierte Parteien können über den Veranstaltungsbereich der Tarsus-Website auf einen Live-Stream zugreifen. Aufzeichnungen der Wiederholungen werden innerhalb von 48 Stunden nach jeder Veranstaltung verfügbar sein und für eine bestimmte Zeit zugänglich bleiben.
- None.
- None.
IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences:
- The Guggenheim SMID Cap Biotech Conference on Thursday, February 6th, at 6:00 a.m. PT / 9:00 a.m. ET
- The Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12th, at 7:00 a.m. PT / 10:00 a.m. ET
A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution,
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When is Tarsus Pharmaceuticals (TARS) presenting at the Guggenheim SMID Cap Biotech Conference in 2025?
What time is Tarsus (TARS) presenting at the Oppenheimer Healthcare Conference in February 2025?
How can investors access the Tarsus (TARS) investor conference presentations in February 2025?